FDA panel recommends approval of Cygnus's continuous glucose monitor
This article was originally published in Clinica
Executive Summary
An advisory panel to the US FDA has unanimously recommended approval of Cygnus's GlucoWatch Biographer, a wristwatch-like device that enables diabetics to monitor their blood sugar levels closely despite using as few as one fingerstick a day. The panel made its recommendation subject to three easily manageable conditions.